China Resources Sanjiu Medical & Pharmaceutical Co Ltd (000999) — Cash Flow Quality Index
China Resources Sanjiu Medical & Pharmaceutical Co Ltd (000999) has a Cash Flow Quality Index of 0.24x as of September 2025. Operating cash flow of CN¥126.71 Million is below net income of CN¥537.57 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore China Resources Sanjiu Medical & Pharmac strategic investment ratio to see how much of total assets are deployed in long-term investments.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
China Resources Sanjiu Medical & Pharmaceutical Co Ltd Cash Flow Quality Index (1999–2024)
Historical Cash Flow Quality Index for China Resources Sanjiu Medical & Pharmaceutical Co Ltd across 25 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check China Resources Sanjiu Medical & Pharmac tangible equity quality to evaluate the tangible quality of the company's equity base.
Annual Cash Flow Quality Index for China Resources Sanjiu Medical & Pharmaceutical Co Ltd (1999–2024)
Year-by-year earnings quality comparison for China Resources Sanjiu Medical & Pharmaceutical Co Ltd. For live market cap and the full company financial profile, see market cap of China Resources Sanjiu Medical & Pharmac.
| Year | Quality Index | Operating CF (CNY) | Net Income | YoY Change |
|---|---|---|---|---|
| 2024 | 1.17x | CN¥4.40 Billion | CN¥3.78 Billion | ▼ -21.2% |
| 2023 | 1.48x | CN¥4.22 Billion | CN¥2.85 Billion | ▲ +22.9% |
| 2022 | 1.20x | CN¥3.01 Billion | CN¥2.50 Billion | ▲ +33.9% |
| 2021 | 0.90x | CN¥1.87 Billion | CN¥2.08 Billion | ▼ -34.6% |
| 2020 | 1.37x | CN¥2.22 Billion | CN¥1.62 Billion | ▲ +49.2% |
| 2019 | 0.92x | CN¥1.97 Billion | CN¥2.14 Billion | ▼ -28.9% |
| 2018 | 1.30x | CN¥1.91 Billion | CN¥1.47 Billion | ▲ +10.2% |
| 2017 | 1.18x | CN¥1.56 Billion | CN¥1.33 Billion | ▲ +2.1% |
| 2016 | 1.15x | CN¥1.39 Billion | CN¥1.21 Billion | ▲ +16.6% |
| 2015 | 0.99x | CN¥1.26 Billion | CN¥1.27 Billion | ▼ -10.5% |
| 2014 | 1.10x | CN¥1.18 Billion | CN¥1.07 Billion | ▼ -8.6% |
| 2013 | 1.21x | CN¥1.47 Billion | CN¥1.21 Billion | ▲ +7.8% |
| 2012 | 1.12x | CN¥1.21 Billion | CN¥1.08 Billion | ▼ -4.3% |
| 2011 | 1.17x | CN¥954.90 Million | CN¥815.13 Million | ▲ +18.6% |
| 2010 | 0.99x | CN¥848.28 Million | CN¥859.10 Million | ▼ -12.1% |
| 2009 | 1.12x | CN¥855.05 Million | CN¥761.59 Million | ▼ -45.6% |
| 2008 | 2.06x | CN¥1.12 Billion | CN¥541.14 Million | ▼ -3.2% |
| 2007 | 2.13x | CN¥605.30 Million | CN¥284.09 Million | ▼ -16.6% |
| 2006 | 2.55x | CN¥425.51 Million | CN¥166.56 Million | ▲ +1206.9% |
| 2005 | 0.20x | CN¥22.83 Million | CN¥116.77 Million | ▲ +55.2% |
| 2003 | 0.13x | CN¥28.09 Million | CN¥223.03 Million | ▼ -96.1% |
| 2002 | 3.23x | CN¥496.12 Million | CN¥153.45 Million | ▲ +161.6% |
| 2001 | 1.24x | CN¥153.44 Million | CN¥124.14 Million | ▼ -4.7% |
| 2000 | 1.30x | CN¥266.86 Million | CN¥205.76 Million | ▲ +147.8% |
| 1999 | 0.52x | CN¥120.63 Million | CN¥230.47 Million | — |